Pillstats
Rx only · Tablet · Oral

Colesevelam Hydrochloride

Colesevelam Hydrochloride

5 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US6 NDCs
5 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCC10AC04
RxCUI (US)141626
US makers5 labelers
Packages6
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.083$0.167$0.250$0.334Dec 2025Apr 2026Jul 2026
$0.268
Latest avg · Jul 22, 2026
-5%
Since Dec 17, 2025
5
Active US suppliers
50%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

4959901.5K2.0K2025 Q12025 Q22025 Q32025 Q42026 Q1
1.7K
Rx · 2026 Q1
257K
Units dispensed
+35%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it5 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
A-S Medication Solutionsunknown2SUPPLYING
Golden State Medical Supply, Inc.unknown1SUPPLYING
Dr.Reddy's laboratories Limitedunknown1SUPPLYING
Cranbury Pharmaceuticals, LLCunknown1SUPPLYING
Bionpharma Inc.unknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.